MedTrace Logo

Massive Implants the Next Generation

NCT03905174 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-06-07

No results posted yet for this study

Summary

The study will review the use of massive segmental replacements in the femur, which have a porous collar with and without HA, and autologous stem cell augment. This is a randomised controlled trial.

Conditions

  • Bone Cancer
  • Bone Diseases

Interventions

DEVICE

custom made device

surgical intervention to place custom made orthopaedic device

Sponsors & Collaborators

  • Adler Ortho

    collaborator UNKNOWN

  • Iva Hauptmannova

    lead OTHER

Principal Investigators

  • Panos Gikas, PhD FRCS · Royal National Orthopaedic Hospital NHS Trust

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-20
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03905174 on ClinicalTrials.gov